Security News > 2020 > November > COVID-19 Antigen Firm Hit by Malware Attack
Over the past two weeks, global biotech firm Miltenyi has been battling a malware attack on its IT infrastructure, the company said in a recent disclosure to its customers.
The firm is currently supplying SARS-CoV-2 antigens for researchers working on treatments for COVID-19.
Miltenyi's compromise appears to be yet another in a series of attacks on companies working on COVID-19 treatments and vaccines.
COVID-19 manufacturer Dr. Reddy's Laboratories suffered an attack in October which forced it to shut down plants across Brazil, India, the U.K and the U.S. The Indian-based company is contracted to manufacture Russia's "Sputnik V" COVID-19 vaccine.
There are currently two COVID-19 vaccines that ABC reports are nearly ready for wide distribution, both the one from Moderna and another from Pfizer that appears to be 90 percent effective against COVID-19.
News URL
https://threatpost.com/covid-19-antigen-malware-attack/161317/
Related news
- Silver Fox APT Uses Winos 4.0 Malware in Cyber Attacks Against Taiwanese Organizations (source)
- ⚡ THN Weekly Recap: GitHub Supply Chain Attack, AI Malware, BYOVD Tactics, and More (source)
- Chinese FamousSparrow hackers deploy upgraded malware in attacks (source)
- Open-source malware doubles, data exfiltration attacks dominate (source)
- Microsoft Warns of Tax-Themed Email Attacks Using PDFs and QR Codes to Deliver Malware (source)